BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PF-08065010 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of PF-08065010\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07235163-11274@assetmemo.bio
DTSTAMP:20261121T005344Z
DTSTART;VALUE=DATE:20270901
DTEND;VALUE=DATE:20270902
SUMMARY:PF-08065010: Phase 1 readout est. (NCT07235163)
DESCRIPTION:PF-08065010\, phase 1.\nStudy: A Study to Learn How Different A
 mounts of the Study Medicine Called PF-08065010 Are Tolerated and Act in t
 he Body of Healthy Adults\nEstimated primary completion: 1 September 2027.
  This is a ClinicalTrials.gov estimate\, not a confirmed readout date\, an
 d it can move.\nDrug page: https://assetmemo.bio/drug/pf-08065010#upcoming
 -events\nRegistry record: https://clinicaltrials.gov/study/NCT07235163
URL:https://assetmemo.bio/drug/pf-08065010#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
